MASTINI, CRISTINA
MASTINI, CRISTINA
DIPARTIMENTO DI MEDICINA E CHIRURGIA (SCHOOL OF MEDICINE AND SURGERY)
Efficacy of a cancer vaccine against ALK-rearranged lung tumors
2015 Voena, C; Menotti, M; Mastini, C; Di Giacomo, F; Longo, D; Castella, B; Merlo, M; Ambrogio, C; Wang, Q; Minero, V; Poggio, T; Martinengo, C; D'Amico, L; Panizza, E; Mologni, L; Cavallo, F; Altruda, F; Butaney, M; Capelletti, M; Inghirami, G; Jänne, P; Chiarle, R
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependency
2016 Ceccon, M; Merlo, M; Mologni, L; Poggio, T; Varesio, L; Menotti, M; Bombelli, S; Rigolio, R; Manazza, A; Di Giacomo, F; Ambrogio, C; Giudici, G; Casati, C; Mastini, C; Compagno, M; Turner, S; GAMBACORTI PASSERINI, C; Chiarle, R; Voena, C
Immune Recognition of ALK Fusion Proteins in Patients with ALK-Rearranged Non-Small Cell Lung Cancer
2017 Awad, M; Mastini, C; Patino, R; Mologni, L; Voena, C; Mussolin, L; Mach, S; Adeni, A; Lydon, C; Janne, P; Chiarle, R
Epitope mapping of spontaneous autoantibodies to anaplastic lymphoma kinase (ALK) in non-small cell lung cancer
2017 Awad, M; Mastini, C; Blasco, R; Mologni, L; Voena, C; Mussolin, L; Mach, S; Adeni, A; Lydon, C; Sholl, L; Jänne, P; Chiarle, R
Lorlatinib treatment elicits multiple on- and off-target mechanisms of resistance in ALK-driven cancer
2018 Redaelli, S; Ceccon, M; Zappa, M; Geeta, G; Mastini, C; Mauri, M; Nigoghossian, M; Massimino, L; Cordani, N; Farina, F; Piazza, R; Gambacorti-Passerini, C; Mologni, L
Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma
2019 Menotti, M; Ambrogio, C; Cheong, T; Pighi, C; Mota, I; Cassel, S; Compagno, M; Wang, Q; Dall’Olio, R; Minero, V; Poggio, T; Geeta, G; Patrucco, E; Mastini, C; Choudhari, R; Pich, A; Zamo, A; Piva, R; Giliani, S; Mologni, L; Collings, C; Kadoch, C; Gambacorti-Passerini, C; Notarangelo, L; Anton, I; Voena, C; Chiarle, R
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia
2020 Fontana, D; Ramazzotti, D; Aroldi, A; Redaelli, S; Magistroni, V; Pirola, A; Niro, A; Massimino, L; Mastini, C; Brambilla, V; Bombelli, S; Bungaro, S; Morotti, A; Rea, D; Stagno, F; Martino, B; Campiotti, L; Caocci, G; Usala, E; Merli, M; Onida, F; Bregni, M; Elli, E; Fumagalli, M; Ciceri, F; Perego, R; Pagni, F; Mologni, L; Piazza, R; Gambacorti-Passerini, C
Synergistic drug combinations prevent resistance in ALK+ anaplastic large cell lymphoma
2021 Arosio, G; Sharma, G; Villa, M; Mauri, M; Crespiatico, I; Fontana, D; Manfroni, C; Mastini, C; Zappa, M; Magistroni, V; Ceccon, M; Redaelli, S; Massimino, L; Garbin, A; Lovisa, F; Mussolin, L; Piazza, R; Gambacorti Passerini, C; Mologni, L
Synergistic drug combinations preventdrug resistance in anaplastic large cell lymphomapreclinical models
2021 Sharma, G; Arosio, G; Villa, M; Mauri, M; Zappa, M; Magistroni, V; Ceccon, M; Redaelli, S; Crespiatico, I; Fontana, D; Mastini, C; Garbin, A; Lovisa, F; Mussolin, L; Piazza, R; Gambacorti Passerini, C; Mologni, L
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience
2022 Steidl, C; Aroldi, A; Mologni, L; Crespiatico, I; Fontana, D; Mastini, C; Fumagalli, M; Perfetti, P; Borin, L; Valentini, C; Piazza, R; Gambacorti-Passerini, C
Characterization of the transcriptional landscape of atypical Chronic Myeloid Leukemia at single-cell resolution
2022 Fontana, D; Crippa, V; Bassi, G; D'Aliberti, D; Mauri, M; Spinelli, S; Mastini, C; Bombelli, S; Civettini, I; Guglielmana, V; Perego, R; Ramazzotti, D; Mologni, L; Piazza, R; Gambacorti Passerini, C